健康去哪儿
健趣网登录 关闭
还没有账号?立即注册

Registry Evaluating AF Ablation Techniques

赞助:
合作者:
信息的提供 (责任方):
Anne-Marie Noten,Erasmus Medical Center
September 20, 2018
October 4, 2018
October 4, 2018
October 1, 2018
October 2019   (主要结果测量的最终数据收集日期)
Procedure time[ Time Frame: During ablation procedure ]
Procedure time (minutes)

Fluoroscopy time[ Time Frame: During ablation procedure ]
Fluoroscopy time (minutes)

Transseptal time[ Time Frame: During ablation procedure ]
Transseptal time (time from insertion of catheters until transseptal puncture) (minutes)

Left atrial dwell time[ Time Frame: During ablation procedure ]
Left atrial dwell time (time from LA entry until removal of catheters) (minutes)

PVI ablation time[ Time Frame: During ablation procedure ]
PVI ablation time (total PVI ablation time, i.e. first until last application) (minutes)

Ablation time per pulmonary vein[ Time Frame: During ablation procedure ]
Ablation time per pulmonary vein (minutes)

与当前相同
  • First Pass Isolation[ Time Frame: During ablation procedure ]
    First Pass Isolation (i.e. Successful isolation of PVs after the first ablation attempt)
  • Acute success[ Time Frame: During ablation procedure ]
    Acute success (Successful electrical isolation of PVs at the end of procedure)
  • TouchUp rates[ Time Frame: During ablation procedure ]
    TouchUp rates (additional applications for successful PV isolation)
  • Long-term success[ Time Frame: From the date of procedure until 1 year ]
    Long-term success (freedom of atrial fibrillation 12 months after ablation)
  • Procedure-related adverse-events[ Time Frame: From the date of procedure until 7 days ]
    Procedure-related adverse-events
  • Long-term adverse events[ Time Frame: From the date of procedure until 1 year ]
    Long-term adverse events
 
Registry Evaluating AF Ablation Techniques
Prospective, Multicenter, Non-randomized Observational Registry Conducted at High Volume Experienced Treatment Centers Utilizing the Most Current AF Ablation Techniques.

The purpose of this observational registry is to prospectively collect procedure efficiency, safety and acute and long term outcome data from catheter ablation procedures as treatment of paroxysmal atrial fibrillation, using the following treatment modalities: - Cryoballoon ablation - Manual guided RF ablation using Contact Force catheters - Remote Magnetic Navigation guided RF ablation with e-Contact and high power settings - Remote Magnetic Navigation guided RF ablation with e-Contact and low power settings

Observational [Patient Registry]
分配:
干预模型:
干预模型描述:
盲法: Observational [Patient Registry]
盲法描述:
主要目的:
  • :
  • : Manual guided RF ablation
    Patients with paroxysmal atrial fibrillation treated with Manual guided RF ablation using Contact Force catheters
  • : Cryoballoon ablation
    Patients with paroxysmal atrial fibrillation treated with Cryoballoon ablation. Cryoballoon: Arctic Front Advance, Medtronic - 28 mm
  • : RMN guided RF ablation - High power
    Patients with paroxysmal atrial fibrillation treated with Remote Magnetic Navigation guided RF ablation with e-Contact and high power settings. High power ablation settings: a minimum of 40 Watt, 43grC, flow 17ml/min. Higher voltages (e.g. anterior wall) are allowed with respect to the operators' preference.
  • : RMN guided RF ablation - Low power
    Patients with paroxysmal atrial fibrillation treated with Remote Magnetic Navigation guided RF ablation with e-Contact and low power settings. Low power ablation settings: a maximum of 39 Watt, 43grC, flow 17ml/min. Lower voltages are allowed with respect to the operators' preference.
 
Not yet recruiting
600
与当前相同
October 2022
October 2019   (主要结果测量的最终数据收集日期)
Inclusion Criteria: - Documented Paroxysmal Atrial Fibrillation - Eligibility for Pulmonary Vein Isolation by catheter ablation based on the respective ACC/AHA/ESC Guideline valid at the date of procedure - Signed the informed consent to participate in the registry Exclusion Criteria: - Younger than 18 years of age - Prior AF ablation procedure (including MAZE procedure) - Prior ablation of Non-AF Arrhythmia within 3 months of enrollment - Presence of cardiac thrombus - Other AF ablations performed during procedure (e.g. lines, rotor, CFAE's etc) - Active endocarditis or systemic infection - Life expectancy < 1 year - Pregnancy
参与研究的性别: All
最小年龄:18 Years ,最大年龄:N/A  
没有
 
No
研究美国FDA监管的药品: No
研究涉及美国FDA监管的设备产品: No
计划分享 IPD: No
Anne-Marie Noten,Erasmus Medical Center
Erasmus Medical Center
:
Erasmus Medical Center
October 2018

ICMJE     国际医学期刊编辑委员会和 世界卫生组织 ICTRP 要求的元素
请使用微信扫码报名